Exercise-Powered immune cells take on leukemia in first human trial
NCT ID NCT07254793
First seen Jan 04, 2026 · Last updated May 02, 2026 · Updated 19 times
Summary
This early study tests a new approach using donor immune cells that are boosted by exercise to prevent or treat leukemia relapse after a stem cell transplant. About 94 people with blood cancers will receive these special cells either to prevent relapse or treat any remaining disease. The goal is to see if this method is safe and works better than standard donor cell infusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
The University of Arizona Cancer Center
Tucson, Arizona, 85719, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.